Similar trends were seen in thyroid stimulating hormone secretion.
Mild diffuse symmetrical uptake may be seen in normal thyroid glands, in diffuse goitres or in autoimmune thyroiditis, whereas focal uptake may be seen in adenomatous nodules and thyroid malignancy [2, 6, 7, 8, 62, 63].
The scattered mononuclear infiltration typical of thyr-IFNγ transgenic mice, instead, was not affected by the absence of LMP2, and lymphocytes could still be seen in the thyroid interstitium of thyr-IFNγ transgenic-LMP2 knockout mice (Figure 4A middle panel).
Diffuse symmetrical uptake may be seen in a normal thyroid as well as in autoimmune thyroiditis.
Nevertheless, a cystic component may be seen in 13 26% of thyroid cancers and 6% of papillary carcinoma of the thyroid may be predominantly cystic.
Thyroid calcifications on a CT scan can be seen in both benign and malignant thyroid lesions [1].
This same phenomenon may also be seen in certain but not all types of thyroid cancer, which could possibly explain the intermediate (partly overlapping, partly distinct) nature of this dataset as well.
Hypervascular metastases can be seen in endocrine tumours such as islet cell, thyroid and carcinoid.
Compared with the corresponding normal tissues, positive amplification of c-Myc was detected in the thyroid cancers, while little c-Myc was seen in the thyroid adenomas.
Physiologic distribution of 18F-TFB is seen in the thyroid, salivary glands, stomach, and intestines.
